Clinical Trials Logo

Hip Arthropathy clinical trials

View clinical trials related to Hip Arthropathy.

Filter by:

NCT ID: NCT06099223 Completed - Anxiety Clinical Trials

Preoperative Acupuncture for Total Knee or Hip Arthroplasty

(Acupuncture)
Start date: March 21, 2022
Phase: N/A
Study type: Interventional

Open-label, randomized controlled trial to determine the effect of preoperative acupuncture on preoperative anxiety and postoperative pain for high-anxiety patients undergoing total hip or knee arthroplasty. The hypothesis is that preoperative acupuncture will reduce preoperative anxiety, reduce postoperative pain, reduce postoperative nausea and vomiting, reduce opioid consumption, and improve patient satisfaction.

NCT ID: NCT06096168 Recruiting - Hip Arthropathy Clinical Trials

Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems

2022-10
Start date: April 13, 2023
Phase:
Study type: Observational

This clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. In order to reflect current practice, a comprehensive and continuous series of patients will be included. This study will confirm the performance and safety of the SAGITTA EVL R revision femoral stems within the framework of MDR 2017/745 and in relation to the recommendations of the MEDDEV guide 2.7.1. Rev 4 (Clinical Evaluation Guide), which provides for a systematic procedure to monitor clinical data in order to verify the claimed performance of medical devices.

NCT ID: NCT06096155 Recruiting - Hip Arthropathy Clinical Trials

Ambispective Study to Assess the Safety and the Performance of SAGITTA EVL R Stem

2022-09
Start date: June 13, 2023
Phase:
Study type: Observational

This clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. This study will confirm the performance and safety of the SAGITTA EVL R revision femoral stems within the framework of MDR 2017/745 and in relation to the recommendations of the MEDDEV guide 2.7.1. Rev 4 (Clinical Evaluation Guide), which provides for a systematic procedure to monitor clinical data in order to verify the claimed performance of medical devices. The primary objective is to evaluate the long-term survival rate (7 to 10 years post-op +/- 2 years) of SAGITTA EVL R stems. Secondary objectives are to : - study long term patient satisfaction with their hip prosthesis, - confirm the long-term safety of these implants by studying the possible complications observed, - evaluate the performance of these implants using clinical scores.

NCT ID: NCT06083428 Completed - Hip Osteoarthritis Clinical Trials

Erector Spinae vs. PENG Block for Total Hip Arthroplasty

Start date: October 17, 2023
Phase: Phase 4
Study type: Interventional

Effect of PENG block and ESPB on pain management, and NLR and PLR following knee arthroplasty

NCT ID: NCT06017128 Not yet recruiting - Quality of Life Clinical Trials

Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: A PLISSIT Model Study

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

This study investigates the influence of sexual counseling using the PLISSIT model on various aspects of patients undergoing hip replacement. The PLISSIT model is employed to guide the counseling process. The research aims to assess how this counseling intervention affects sexual function, quality of life, and overall comfort for these patients. By addressing these factors, the study seeks to shed light on potential improvements in the well-being and experiences of individuals who have undergone hip replacement surgery.

NCT ID: NCT05956236 Recruiting - Hip Arthropathy Clinical Trials

Hip Prospective Study

Start date: April 24, 2023
Phase:
Study type: Observational

In an evaluation report dated 2014, the HAS (Haute Autorité de Santé -French National Authority for Health) highlights that long-term clinical data on hip prostheses are needed in the context of the French healthcare system. In addition, per the European Regulation 2017/745, medical devices manufacturers shall conduct Post-Market Clinical Follow-up (PMCF) on their devices or provide a justification why PMCF is not applicable. Therefore, as part of the PMCF process of their hip prostheses, SERF wants to conduct a PMCF investigation to ensure the long-term real-life performance, safety and benefits of these prostheses. HiPS is a non-comparative, prospective, multicentric, national, 15-year follow-up clinical investigation.

NCT ID: NCT05947734 Completed - Hip Arthropathy Clinical Trials

Robot Assisted Total Hip Arthroplasties

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This is a randomized controlled, multicenter study. According to the inclusion criteria, volunteers were recruited from patients undergoing total hip arthroplasty. After signing the informed consent, the subjects were assigned to the experimental group and the control group through the central randomization system. The researchers will complete the total hip arthroplasty for patients in the experimental group with the assistance of surgical robotic system. The patients in the control group do not use the surgical robotic system. The proportion of acetabular abduction angle and anteversion angle in the lewinnek safe area is the primary outcome measurement. The operation time, WOMAC score, Harris score, SF-36 and dislocation rate are the secondary outcome measurements. The incidence of complications, devices and other adverse events were recorded.

NCT ID: NCT05944380 Completed - Hip Osteoarthritis Clinical Trials

PENG Block for Total Hip Arthroplasty

Start date: June 16, 2020
Phase: Phase 4
Study type: Interventional

This randomized, double-blinded, placebo-controlled trial seeks to evaluate the efficacy of the pericapsular nerve group block on postoperative rehabilitation.

NCT ID: NCT05916209 Completed - Hip Arthropathy Clinical Trials

PENG and LFCN Block Versus FIC Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis

PENG+LFCN-FICB
Start date: February 1, 2023
Phase:
Study type: Observational

Background: Optimal pain control with limited muscle weakness is paramount for a swift initiation of physical therapy and ambulation. Fascia iliaca compartment block (FICB) has been recommended since it offers the best pain control with low risk of motor block. Pericapsular nerve group block (PENG) with lateral femoral cutaneous nerve (LFCN) block has been proposed as an effective alternative to FICB that offers similar pain control with a considerably lower risk of motor block. This study aimed to compare the afore mentioned blocks and determine which one yielded the lowest NRS score.

NCT ID: NCT05882656 Active, not recruiting - Hip Arthropathy Clinical Trials

Quality of Life, Functional Outcomes and Costs in Hip Arthroplasty

Start date: June 1, 2023
Phase:
Study type: Observational

This prospective observational study aims to collect and analyse data on functional outcomes, quality of life indicators, and costs in patients undergoing primary total hip arthroplasty (hip replacement) surgery.